Health
BioNTech/Pfizer vaccine is less potent against South African variant – Financial Times
Covid-19 jab still works but produces only a third of the antibodies it did for original virus, study finds
The BioNTech/Pfizer Covid-19 vaccine appears to be significantly less effective against the virus variant that emerged in South Africa, according to a study published on Wednesday.
The vaccine still works against the strain known as 501Y.V2, but the shot produced only a third of the antibodies that it did for the original virus in a lab study using an engineered virus.
The partners said there was “no clinical evidence” that people vaccinated with their Covid-19 shot lacked protection against the…
-
Noosa News23 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News22 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Business9 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General18 hours ago‘Potential’ hacker contacts Qantas over data breach